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Information on problem drug use is collected by the National Drug Treatment Reporting
System (NDTRS). The NDTRS is an epidemiological database on treated drug misuse. It was
established in 1990 in the Greater Dublin Area only. In 1995 it was extended to other parts
of the country; the North Eastern Health Board (NEHB) began making full data returns in
1998. The objectives of the NDTRS are to provide reliable information on the number and
characteristics of people who are treated for problem drug use; and to examine trends and
patterns of problem drug use. It provides information relevant to the health consequences
and social implications of drug misuse and contributes to an understanding of the
epidemiology of drug misuse in Ireland. This series of papers presents data by regional
health board areas. 
NDTRS methodology
Background
Data on treated drug misuse are routinely collected by staff at drug treatment agencies
throughout Ireland. In NEHB area data collection is co-ordinated by a Regional Co-ordinator.
Compliance with the NDTRS requires that a form be completed for each person who receives
treatment for problematic drug use. At national level, aggregated anonymous data are
compiled by the Drug Misuse Research Division (DMRD), Health Research Board (HRB).  
For the purpose of the NDTRS, treatment is broadly defined as ‘any activity which aims to
ameliorate the psychological, medical or social state of individuals who seek help for their drug
problems’. Treatment may therefore include non-medical (addiction counselling, group therapy,
psychotherapy), as well as medical interventions (detoxification, methadone substitution
programmes).    
The main elements of the reporting system are: 
a) All Treatment Contacts – the reporting of all clients receiving treatment during a given year,
and 
b) First Treatment Contacts – the reporting of the sub-group of clients who have never previously
been treated for problem drug use.
In the case of the ‘all contact’ data there is a possibility of duplication in the database, for
example, where a person receives treatment at more than one centre. This is estimated to be
small since the introduction of the Misuse of Drugs Regulations in 1998, whereby precautions are
taken to ensure that treatment by way of medical prescription is available from one source only.  
Treatment as an indicator of drug misuse
Drug treatment data are viewed as an indirect indicator of drug misuse and are used at
national and European levels to provide information on the characteristics of clients entering
treatment, and patterns of drug misuse such as types of drugs used and consumption
behaviours. They are ‘valuable from a public health perspective to assess needs, … and to
plan and evaluate services’ (EMCDDA, 1998: 23). Information from the NDTRS is made
available to service providers and policy makers and forms an important element in
Table 1a. Number of All Treatment Contacts* by treatment area and area of residence of clients,
1996-2000
Year Total treated in NEHB NEHB residents NEHB residents Others treated in Total NEHB residents
treated in NEHB treated elsewhere NEHB treated
1996 Na Na 49 Na 49
1997 Na Na 94 Na 94
1998 71 69 59 2 128
1999 123 123 32 0 155
2000 250 243 22** 7 265**
* Number of cases, as distinct from individuals, who received treatment for their problem drug use
** Provisional figures due to incomplete returns from the Eastern Regional Health Authority health boards
Na: Not available
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In 1997 financial resources were allocated for the improvement of drug treatment services in the NEHB area.
Consequently over the past three years a number of initiatives have been undertaken to improve services in
the area. In recognising drug misuse as a serious problem, the NEHB established a Regional Advisory Committee
on Drugs. Partnerships were developed with voluntary groups and parent groups willing to participate with the
Board in implementing its policies. The emphasis of drug policy in the NEHB area is on prevention, health
promotion and drug education. Particular importance is attached to providing services for drug users and their
families (http://www.nehb.ie).
Following the initiatives taken in 1997, reporting to the NDTRS commenced in 1998. Data for NDTRS during
2000 were collected by 8 agencies: all were non-residential. The type of drug treatment provided/availed of
was mainly advice/counselling/support, that is, in 243 out of 250 cases.  
Prior to 1998 all NEHB residents recorded in the NDTRS were receiving treatment for problem drug use
outside of the NEHB area (49 in 1996; 94 in 1997), mainly in the then Eastern Health Board area. In 1998
the number of drug users presenting for treatment2 in the NEHB area was 71 (Table 1a). By 2000 the
number had increased to 250 which was double that of the previous year. In 2000 a total of 264 residents
of the NEHB received treatment for problem drug use, and of these the majority (N=250) received
treatment in the NEHB area (Table 1a). Only 22 NEHB residents were treated elsewhere, probably as a result
of increasing improvements in service provision in the NEHB catchment area. However, this figure (N=22)
may be an under-estimation of the situation due to incomplete data returns from Eastern Regional Health
Authority (ERHA) health board areas to date. 
Extent of the problem
2 The emphasis of this paper is on the illicit drug use of clients who received treatment between 1998 and 2000, in the catchment area covered
by the NEHB (Counties Louth, Meath, Cavan and Monaghan)
Treatment provision
informing local and national drug policies. Based on NDTRS data a number of local areas were targeted
for special attention in 1996. Initially eleven areas, ten in Dublin and one in Cork, all of which were
characterised by social and economic disadvantage, were designated as Local Drug Task Force Areas
(Ministerial Task Force, 1996). There are now fourteen areas: twelve in Dublin; one in Cork; and one in
Bray (Department of Tourism, Sport & Recreation, 2001). Local Drug Task Forces were established with the
aim of providing strategic local responses in areas where drug misuse was a serious problem.
In the Government’s Building on Experience. National Drugs Strategy 2001-2008, the role of the NDTRS is
recognised in ensuring that the overall aims of the strategy are met. NDTRS data collection is one of the
actions identified and agreed by Government for implementation by health boards. It is stated that ‘all
treatment providers should co-operate in returning information on problem drug use to the DMRD of
the HRB’ (Department of Tourism, Sport & Recreation, 2001: 118). 
The emphasis of
drug policy in
the NEHB area is
on prevention,
health
promotion and
drug education
During 2000,
265 NEHB
residents were
treated for
problem drug
use
1 Counties Louth, Meath, Cavan and  Monaghan
Table 1b. Number of First Treatment Contacts* by treatment area and area of residence of 
clients, 1996-2000
Year Total treated in NEHB NEHB residents NEHB residents Others treated in Total NEHB residents
treated in NEHB treated elsewhere NEHB treated
1996 Na Na 35 Na 35
1997 Na Na 53 Na 53
1998 Na Na 27 Na 27
1999 78 78 14 0 92
2000 172 165 16** 7 181**
* Number of people who received treatment for the first time ever
** Provisional figures due to incomplete returns from the Eastern Regional Health Authority health boards
Na: Not available
Table 2a. Socio-demographic characteristics of All Treatment Contacts treated in the NEHB, 
1996-2000
Characteristics 1996 1997 1998 1999 2000
% Males : % Females Na Na 82:18 74:26 85:15
Mean age (years) Na Na 22 23 21
Modal age (years) Na Na 19 21 19
% Under 18 years of age Na Na 20 17 25
% Living with parents/family Na Na Na 68 80
% Early school leavers* Na Na Na 20 11
% Still at school Na Na Na 11 18
% Employed Na Na 47 44 45
* Left school before the age of 15 years
Na: Not available
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The typical client presenting for treatment is male, around 20 years of age and living in the family home
(Table 2a). Clients treated in 2000 were less likely to have left school before the official school leaving
age of 15 years (11 percent) compared to 21 percent the year before (Table 2a). Employment levels did
not change much over the three-year period with a little less than half in employment (Table 2a).
Although these levels are comparatively higher than in other areas of the country, nonetheless they are
indicative of social disadvantage of drug users, especially in a climate of favourable economic conditions.   
Socio-demographic information
A sizeable proportion of those treated in the NEHB are receiving treatment for the first time (first
contacts). The number of first contacts increased from 78 in 1999 to 172 in 2000 (Table 1b).    
The socio-demographic characteristics of new clients (first contacts) are generally quite similar to those of
the overall group of all contacts (Table 2b).    
The typical
client presenting
for treatment is
male, around 20
years of age and
living in the
family home
Table 2b. Socio-demographic characteristics of First Treatment Contacts treated in the NEHB, 
1996-2000
Characteristics 1996 1997 1998 1999 2000
% Males : % Females Na Na Na 78:22 87:13
Mean age (years) Na Na Na 23 21
Modal age (years) Na Na Na 21 20
% Under 18 years of age Na Na Na 17 30
% Living with parents/family Na Na Na 74 83
% Early school leavers* Na Na Na 23 10
% Still at school Na Na Na 13 22
% Employed Na Na Na 51 47
* Left school before the age of 15 years
Na: Not available
Table 3a. Main Drug of Misuse of All Treatment Contacts treated in the NEHB, 1996-2000  
Main Drug of 1996 1997 1998 1999 2000
Misuse N (%) N (%) N (%) N (%) N (%)
Opiates Na Na 21 (30) 29 (24) 36 (14)
Cocaine Na Na 0 (0) 1 (1) 5 (2)
Ecstasy Na Na 7 (10) 15 (12) 42 (17)
Amphetamines Na Na 8 (11) 7 (6) 2 (1)
Benzodiazepines Na Na 1 (1) 3 (2) 2 (1)
Volatile Inhalants Na Na 3 (4) 9 (7) 9 (4)
Cannabis Na Na 31 (44) 58 (47) 153 (61)
Other substances Na Na 0 (0) 1 (1) 1 (0)
Total Na Na 71 123 250
Table 3b. Main Drug of Misuse of First Treatment Contacts treated in the NEHB, 1996-2000 
Main Drug of 1996 1997 1998 1999 2000
Misuse N (%) N (%) N (%) N (%) N (%)
Opiates Na Na Na 11 (14) 15 (9)
Cocaine Na Na Na 0 (0) 3 (2)
Ecstasy Na Na Na 11 (14) 32 (19)
Amphetamines Na Na Na 4 (5) 2 (1)
Benzodiazepines Na Na Na 2 (3) 1 (1)
Volatile Inhalants Na Na Na 6 (8) 8 (5)
Cannabis Na Na Na 44 (56) 110 (64)
Other substances Na Na Na 0 (0) 1 (1)
Total Na Na Na 78 172
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Trends among the sub-group of new clients (first contacts) were similar to those of the overall group (all
contacts) (Table 3b). New clients were however, more likely to be using cannabis and ecstasy, and less likely
to be using an opiate. The use of opiates is relatively low, 15 new clients were treated in 2000 (Table 3b). 
Na: Not available
Na: Not available
A closer scrutiny of all treatment contacts reveals that heroin was the opiate most likely to be used and
that the number of users is on the increase, from 14 in 1998 to 32 in 2000 (Table 4a). In 2000 the
heroin was smoked and injected in equal measure; half (N=16) smoked and half (N=16) injected.   
Trends over the
period 1998 to
2000 show that
treated cannabis
misuse has
increased
Information on the patterns of drug use, such as the types of drugs used, how they are taken, and whether
in combination with other drugs, can be useful in assessing and planning drug treatment services. In the
NEHB area, drug use patterns are generally similar to those in other regions of the country where cannabis
is the main drug causing problems and for which most people present for treatment (O’Brien et al. 2000).
Given that cannabis is smoked, this can have serious implications for the future health of a young
population. Trends over the period 1998 to 2000 show that cannabis misuse has increased.  The numbers
presenting for treatment of cannabis use increased from 31 in 1998 to 153 in 2000 (Table 3a). However
this increase could partly be attributed to the increase in service provision. There was an increase in ecstasy
use, from 10 percent (N=7) in 1998 to 17 percent (N=42) in 2000. While the number of those treated for
opiate problems increased from 21 in 1998 to 36 in 2000, the relative proportion decreased from 30
percent in 1998 to 14 percent in 2000 (Table 3a).
Problem drug use
Table 4a. Opiate as a Main Drug of Misuse for All Treatment Contacts treated in the NEHB, 1996-2000
Main Drug / Route 1996 1997 1998 1999 2000
of Administration N N N N N
Heroin Na Na 14 26 32
of whom:
inject Na Na 7 11 16
smoke Na Na 7 14 16
other route Na Na 0 0 0
not known Na Na 0 1 0
Other Opiates Na Na 7 3 4
Total Na Na 21 29 36
Na: Not available
Table 4b. Opiate as a Main Drug of Misuse for First Treatment Contacts treated in the NEHB, 
1996-2000
Main Drug / Route 1996 1997 1998 1999 2000
of Administration N N N N N
Heroin Na Na Na 9 15
of whom:
inject Na Na Na 3 5
smoke Na Na Na 6 10
other route Na Na Na 0 0
Other Opiates Na Na Na 2 0
Total Na Na Na 11 15
Na: Not available
Table 5a. Secondary Drug of Misuse of All Treatment Contacts treated in the NEHB, 1996-2000 
Secondary Drug 1996 1997 1998 1999 2000
of Misuse N (%) N (%) N (%) N (%) N (%)
No second drug Na Na 21 (30) 62 (50) 79 (32)
Opiates Na Na 10 (14) 3 (2) 8 (3)
Cocaine Na Na 0 (0) 2 (2) 2 (1)
Ecstasy Na Na 14 (20) 21 (17) 59 (24)
Amphetamines Na Na 15 (21) 10 (8) 33 (13)
Benzodiazepines Na Na 0 (0) 1 (1) 4 (2)
Volatile Inhalants Na Na 0 (0) 2 (2) 7 (3)
Cannabis Na Na 8 (11) 20 (16) 39 (16)
Alcohol Na Na 2 (3) 0 (0) 7 (3)
Other substances Na Na 1 (1) 2 (2) 12 (5)
Total Na Na 71 123 250
Na: Not available
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Among new clients, the number using heroin is relatively low, increasing from 9 in 1999 to 15 in 2000. In
contrast to all contacts, new clients were more likely to be smoking rather than injecting heroin (Table 4b).
Trends in secondary drug use indicate that polydrug use is prevalent, with more than two-thirds of
clients in 2000 likely to be involved in the use of more than one drug (Table 5a). Ecstasy, cannabis and
amphetamines were the drugs most likely to be reported. Very few people were reported with alcohol3
problems, which is surprising given that regular use of alcohol is reported to be high among adolescents
(Department of Public Health, 1999).
3 Alcohol may be included as a secondary drug of misuse in the NDTRS. It is NOT included as a main drug
Clients are
likely to be
involved in
polydrug use
Table 6a. Risk Behaviours of All Treatment Contacts treated in the NEHB, 1996-2000
Risk Behaviours 1996 1997 1998 1999 2000
Mean age of initial drug use (years) Na Na Na 15 15
Mean age 1st injected (years) Na Na Na 21 21
Ever Injected  N Na Na 20 21 30
of whom:
‘ever shared’  N Na Na 11 8 14
‘currently injecting’  N Na Na 12 7 11
‘currently sharing’  N Na Na 1 3 3
Na: Not available
Table 6b. Risk Behaviours of First Treatment Contacts treated in the NEHB, 1996-2000
Risk Behaviours 1996 1997 1998 1999 2000
Mean age of initial drug use (years) Na Na Na 16 15
Mean age 1st injected (years) Na Na Na 21 20
Ever Injected  N Na Na Na 6 9
of whom:
‘ever shared’  N Na Na Na 2 4
‘currently injecting’  N Na Na Na 2 3
‘currently sharing’  N Na Na Na 1 3
Na: Not available
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The mean age of initial drug use was very young at 15 years of age (Tables 6a, 6b). The number of clients
who had ever injected increased from 20 in 1998 to 30 in 2000. Of these, a sizeable proportion engaged
in high risk behaviours: in 2000, nearly half (N=14) had shared injecting equipment, and over a third
(N=11) were currently injecting (Table 6a). Although data are available only for three years the trends
over this period present issues of particular concern for the health of drug users and a challenge to
service providers.   
Risk behaviour
Among the first contact sub-group the number who had ever injected increased from 6 in 1999 to 9 in
2000 (Table 6b). Because data are available for only two years it is difficult to review risk behaviour trends
among new clients. 
New clients (first contacts) were as likely to be polydrug users as all contacts (Table 5b).
The mean age
of initial drug
use was very
young at 15
years of age
Table 5b. Secondary Drug of Misuse of First Treatment Contacts treated in the NEHB, 1996-2000 
Secondary Drug 1996 1997 1998 1999 2000
of Misuse N (%) N (%) N (%) N (%) N (%)
No second drug Na Na Na 43 (55) 54 (31)
Opiates Na Na Na 2 (3) 5 (3)
Cocaine Na Na Na 2 (3) 1 (1)
Ecstasy Na Na Na 14 (18) 44 (26)
Amphetamines Na Na Na 6 (8) 22 (13)
Benzodiazepines Na Na Na 0 (0) 2 (1)
Volatile Inhalants Na Na Na 1 (1) 7 (4)
Cannabis Na Na Na 10 (13) 28 (16)
Alcohol Na Na Na 0 (0) 3 (2)
Other substances Na Na Na 0 (0) 6 (3)
Total Na Na Na 78 172
Na: Not available
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Figure 1a. Trends in All Treatment Contact rates for 15 - 39 year olds by Health Board of 
Residence, 1996-2000*. Rates per 10,000 population **
0
20
40
60
80
100
EHB
MHB
MWHB
NEHB
NWHB
SEHB
SHB
WHB
1996 1997 1998 1999 2000
Ra
te
 p
er
 1
0,
00
0 
p
op
ul
at
io
n
Year
Figure 1b. Trends in First Treatment Contact rates for 15 - 39 year olds by Health Board of 
Residence, 1996-2000*. Rates per 10,000 population **
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* Trends for 1996-1999 only in the EHB due to incomplete returns for 2000
** Population figures for each health board are based on the Census for Population 1996, Central Statistics Office
* Trends for 1996-1999 only in the EHB due to incomplete returns for 2000
** Population figures for each health board are based on the Census for Population 1996, Central Statistics Office
Year
Figures 1a and 1b provide a comparison of the rates of treated drug misuse among residents in different health
board areas of Ireland for all and first treatment contacts respectively. As the majority of people treated for
problem drug use are in the 15-39 year age group, the rates were based on this age group of the population
in each health board area. It is immediately obvious that in the ERHA health board areas (formerly EHB) the
rate is much higher than in other regions of the country. However, there is not great variation in regional
trends. In all cases the trend shows an increase in those presenting to drug treatment services (Figure 1a). 
Regional trends
There was an upward trend in first treatment contacts between 1996 and 2000 in all regions
(Figure 1b). Increased provision of services at individual health board level is of course a factor
that must be borne in mind when considering such trends. Where there are accessible drug user
oriented services provided, people are more likely to approach them. However, it would appear
that the upward trends also indicate a real increase in drug misuse.    
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• Data from the NDTRS provide a profile of drug users presenting to the treatment services. This gives planners and service
providers an insight into the number and type of clients availing of treatment services.
• Data on clients receiving treatment for the first time can indicate, over time, changing patterns and trends in problematic drug use.
It is thus possible to distinguish new populations of drug users coming for treatment, from more long term chronic drug users.
• A particular benefit of this database is that it provides a foundation for carrying out other more detailed investigations. The value
increases over time if data are collected systematically for a number of years. Examples include studies of changes in behaviour
patterns in different subgroups, or comparisons with samples of untreated drug users. The DMRD welcomes collaborative
research using the NDTRS database.
• The DMRD will provide to the agency, if required, an analysis of returns made to the NDTRS. This can be very useful to the
agency for end of year appraisal of clients, or for research purposes.
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